Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Analogs of pyridoxal isonicotinoyl hydrazone (PIH) are of interest as iron chelators for the treatment of secondary iron overload and cancer. PIH, salicylaldehyde isonicotinoyl hydrazone (SIH), and 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone (NIH), the toxicity of which vary over two orders of magnitude, were selected for a study of their mechanisms of toxicity. PIH analogs and their iron complexes caused concentration- and time-dependent apoptosis in Jurkat T lymphocytes and K562 cells. Bcl-2 overexpression was partially anti-apoptotic, suggesting mitochondrial mediation of apoptosis. Since the pan-caspase inhibitor zVAD-fmk did not reduce lysosomal and mitochondrial destabilization, these events occur upstream of caspase activation. In contrast, phosphatidylserine externalization and the development of apoptotic morphology were inhibited significantly, indicating the role of caspases in mediating these later events. Since overexpression of CrmA had no effect on apoptosis, caspase-8 is not likely involved. Fe(3+) complexes of SIH and NIH, which accumulated in 59Fe-labeled mouse reticulocytes during incubation with the chelators, also caused apoptosis. BSA, which promotes release of the complexes from cells, reduced the toxicity of SIH and NIH, suggesting that the induction of apoptosis by PIH analogs involves toxic effects mediated by their Fe(3+) complexes. Moreover, analogs of these agents lacking the iron-chelating moiety were non-toxic.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, pyridoxal isonicotinyl hydrazone (PIH) [1672,1715-1720] is a promising molecule (also proposed in anti-cancer therapy), although it is hydrolysed both in vivo and in vitro [1721].”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1718]
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80066-n · Cited by 3,419
Target Protease Specificity of the Viral Serpin CrmA
Zhou, Q., Snipas, S., Orth, K., Muzio, M., Dixit, V. M., & Salvesen, G. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7797 · Cited by 519
Deiss, L. P., Galinka, H., Berissi, H., Cohen, O., & Kimchi, A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00760.x · Cited by 465
Richardson, D., Tran, E., & Ponka, P. (1995) · Blood · doi:10.1182/blood.v86.11.4295.bloodjournal86114295 · Cited by 345
Self-citationNEUZIL, J., WEBER, T., SCHRÖDER, A., LU, M., OSTERMANN, G., GELLERT, N., MAYNE, G. C., OLEJNICKA, B., NÈGRE‐SALVAYRE, A., STÍCHA, M., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0251com · Cited by 287
Self-citationRoberg, K. B., & Öllinger, K. M. (1998) · Europe PMC (PubMed Central) · Cited by 284
Photo-Oxidative Disruption of Lysosomal Membranes Causes Apoptosis of Cultured Human Fibroblasts
Brunk, U. T., Dalen, H., Roberg, K., & Hellquist, H. B. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00007-5 · Cited by 283
Cited by
The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer
Kalinowski, D. S., & Richardson, D. R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.2 · Cited by 721
“More recent studies have confirmed the importance of the ligand and subsequent complex lipophilicity on the iron mobilization activity of these chelators (Buss et al., 2002a, 2003a).”
BackgroundInfluentialKell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“Thus, pyridoxal isonicotinyl hydrazone (PIH) [1507; 1546-1551] is a promising molecule (also proposed in anti-cancer therapy), although it is hydrolysed both in vivo and in vitro [1552].”
BackgroundKell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…the iron (Kell 2009a)—this can be effected when iron is ostensibly depleted (e.g. Bergman et al. 2005; Bidle and Bender 2008; Brard et al. 2006; Buss et al. 2003; Fukuchi et al. 1994; Greene et al. 2002; Haq et al. 1995; Hileti et al. 1995; Jiang et al. 2002; Jin et al. 2007; Koc et al.…”
BackgroundSiderophores: Importance in bacterial pathogenesis and applications in medicine and industry
Khasheii, B., Mahmoodi, P., & Mohammadzadeh, A. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126790 · Cited by 206
Peterson, Q. P., Hsu, D. C., Goode, D. R., Novotny, C. J., Totten, R. K., & Hergenrother, P. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900722z · Cited by 156
Metadata
- Authors
- Buss, J. L., Neuzil, J., Gellert, N., Weber, C., & Ponka, P.
- Affiliations
- Jewish General Hospital (CA)
- Ludwig-Maximilians-Universität München (DE)
- Universitätsklinikum Aachen (DE)
- Corresponding author
- Ponka, Prem
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 65
- Issue
- 2
- Pages
- 161-172
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2068721397
- Cited by
- 42
- References
- 44
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 1 · 2013: 1 · 2012: 2
- FWCI
- 0.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Cooley's Anemia Foundation
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- pyridoxal isonicotinoyl hydrazone, iron chelation, apoptosis, salicylaldehyde isonicotinoyl hydrazone, iron(III) complexes, hematopoietic cells, Jurkat T lymphocytes, K562 cells, Bcl-2, mitochondrial apoptosis, caspase activation, phosphatidylserine exposure, secondary iron overload, cancer therapy, reticulocytes
- MeSH terms
- Ferric Compounds, Hematopoietic Stem Cells, Humans, Iron, Iron Chelating Agents, Isoniazid, Mitochondria, Pyridoxal, Reticulocytes, Apoptosis, Jurkat Cells, K562 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. https://app.cochat.ai/papers/10.1016/s0006-2952(02)01512-5
- The paper
- Buss, J. L., Neuzil, J., Gellert, N., Weber, C., & Ponka, P. (2003). Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. Biochemical Pharmacology. https://doi.org/10.1016/s0006-2952(02)01512-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.